38 results

• Valsartan and Similar Hypertension Drugs Had No Effect On COVID-19 Survival: Study

  January 21, 2021

  Irvin Jackson

  A new study questions whether hypertension drugs have a negative impact on patients with COVID-19 infections.

• Valsartan, Similar Drugs Not Linked To Increased Risks of COVID-19: Study

  July 17, 2020

  Irvin Jackson

  A new study finds that valsartan and similar drugs do not increase the risk of poor outcomes from COVID-19.

• Side Effects of Valsartan, Losartan, Similar Blood Pressure Drugs Do Not Increase Coronavirus Risk: Study

  May 4, 2020

  Irvin Jackson

  New study questions whether hypertension drugs increase severity of COVID-19.

• Popular Blood Pressure Drugs And Diabetes May Increase Coronavirus Risks, Some Researchers Warn

  March 17, 2020

  Irvin Jackson

  Some researcher warn that blood pressure medications like valsartan and Benicar could increase the severity and lethality of the coronavirus.

• Status of Valsartan Recall Claims to be Reviewed at Case Management Conference

  June 25, 2019

  Austin Kirk

  A status conference on Wednesday will discuss how to move valsartan litigation forward with short form complaints and plaintiffs fact sheets.

• Leadership Structure Established for Valsartan Attorneys Involved in Federal Litigation

  May 10, 2019

  Irvin Jackson

  The attorney overseeing all valsartan recall lawsuits has appointed attorneys to various leadership roles in the consolidated litigation over tainted generic blood pressure medications.

• About 2,000 Valsartan Injury Lawsuits Expected Over Cancer-Causing Chemicals in Widely Used Blood Pressure Drug

  May 2, 2019

  Irvin Jackson

  Thousands of valsartan lawsuits may be filed over the coming two years as the recalls expand and more plaintiffs link their cancer cases to use of the tainted drugs.

• Valsartan Lawyers To Be Appointed To Leadership Position After Next MDL Conference

  April 17, 2019

  Irvin Jackson

  A federal judge is expected to select attorneys for leadership positions in valsartan recall litigation by the end of the month.

• Direct Filing of Valsartan Recall Cases Permitted in Federal Multidistrict Litigation

  April 11, 2019

  Austin Kirk

  Plaintiffs can now file valsartan recall lawsuits over cancer injuries directly with the MDL court in New Jersey

• FDA Releases List of 40 Hypertension Drugs That Do Not Contain Potentially Cancer-Causing Impurities

  April 5, 2019

  Irvin Jackson

  The FDA is providing a list of 40 blood pressure medications it says are free of cancer-causing impurities, but warns that shortages will increase beyond valsartan.